Welcome to our dedicated page for Exponent news (Ticker: EXPO), a resource for investors and traders seeking the latest updates and insights on Exponent stock.
Exponent Inc (EXPO) is a global leader in multidisciplinary engineering and scientific consulting, addressing complex challenges across industries from transportation to healthcare. This page serves as the definitive source for all company announcements, financial updates, and strategic developments.
Investors and industry stakeholders will find curated EXPO news including earnings reports, partnership announcements, and operational updates. Key updates cover engineering consulting innovations, safety analysis advancements, and regulatory compliance insights that demonstrate the company's technical leadership.
Bookmark this page to track EXPO's progress in solving high-stakes technical challenges through press releases detailing new service offerings, expert commentary on industry trends, and corporate milestones. All content is verified for accuracy and updated systematically to support informed decision-making.
Exponent, Inc. (Nasdaq:EXPO) will report its fourth quarter and fiscal year 2021 financial results on February 3, 2022, after market close. The announcement will be followed by a conference call hosted by CEO Dr. Catherine Corrigan and CFO Richard Schlenker at 4:30 PM ET. Investors can access the live call via phone or join the webcast from the Investor Relations section of Exponent's website. This call aims to provide insights into the company's financial performance and business developments for the fiscal year.
Exponent, Inc. (Nasdaq: EXPO) announced that Dr. Catherine Corrigan and Richard Schlenker will present at the Berenberg US CEO Conference.
The conference is scheduled for Tuesday, November 9, 2021, from 12:00 PM to 12:45 PM PT. A webcast of the presentation will be available on the investor relations section of the Exponent website, with an archived replay accessible post-event.
Exponent provides engineering and scientific consulting solutions, leveraging over 50 years of experience in analyzing complex challenges.
Exponent, Inc. (Nasdaq:EXPO) has declared a quarterly cash dividend of $0.20 per share, payable on December 17, 2021, to shareholders of record as of December 3, 2021. The company plans to continue quarterly dividends each year in March, June, September, and December, contingent on Board approval. CEO Dr. Catherine Corrigan highlighted the company’s strong cash flow and balance sheet, affirming their commitment to high-quality data analytics and long-term shareholder value.
Exponent, Inc. (Nasdaq: EXPO) reported a solid third quarter for fiscal year 2021, with net revenues increasing by 16% to $116.4 million and net income rising to $24.6 million or $0.46 per diluted share. EBITDA improved to $34 million, representing 31.4% of net revenues. The company anticipates mid-single digit revenue growth for Q4 and a decrease in EBITDA margins between 175 to 225 basis points.
Overall, Exponent remains focused on expanding its multidisciplinary services amid growing demand and aims for profitable growth across various sectors.
Exponent, Inc. (Nasdaq: EXPO) will announce its third-quarter fiscal 2021 financial results on October 28, 2021, after market close. CEO Dr. Catherine Corrigan and CFO Richard Schlenker will lead a conference call at 4:30 p.m. ET to discuss the results. Interested parties can access the call via phone or through the company's Investor Relations webpage, where an archived version will also be available later. The firm specializes in engineering and scientific consulting, leveraging decades of expertise to solve complex problems for clients.
Exponent Inc. (Nasdaq: EXPO) has declared a quarterly cash dividend of $0.20 per share, payable on September 24, 2021, to stockholders of record as of September 10, 2021. This decision reflects the company’s strong balance sheet and business resilience. Exponent aims to continue its quarterly dividend payouts in March, June, September, and December. CEO Dr. Catherine Corrigan highlighted the firm’s commitment to delivering valuable solutions to complex challenges, ensuring long-term shareholder value.
Exponent, Inc. (Nasdaq: EXPO) reported strong Q2 2021 results, with net revenue up 30% to $119.9 million, driven by robust demand post-pandemic. EBITDA margin expanded 630 basis points year-over-year, reaching 32.3% of net revenues. Net income increased to $25.4 million, or $0.48 per diluted share, compared to $16.3 million in Q2 2020. The company maintains a positive outlook for the remainder of the year, expecting low-double digit revenue growth and increased EBITDA margins. Exponent reported $240 million in cash and repurchased $7 million of stock.
Exponent, Inc. (EXPO) will report its Q2 fiscal year 2021 financial results on July 29, 2021, after market close. Dr. Catherine Corrigan, CEO, and Richard Schlenker, CFO, will host a conference call at 4:30 p.m. ET to discuss the results. The call will be accessible via a live and archived webcast on the company's Investor Relations website. A telephonic replay will be available until August 5, 2021. Exponent specializes in engineering and scientific consulting, leveraging over 50 years of experience in solving complex problems across various technical disciplines.
Exponent, Inc. (NASDAQ: EXPO) announced the appointment of John Doyle, Dr.P.H., as Group Vice President, Health Sciences on May 17, 2021. Dr. Doyle will lead the company's Health Sciences team, addressing environmental, occupational, medical, and public health challenges. CEO Dr. Catherine Corrigan highlighted Dr. Doyle's experience in healthcare research and the pharmaceutical sector, aiming to drive growth in life sciences. Dr. Doyle has authored over 200 research articles, primarily in oncology, and holds advanced degrees in Epidemiology from Columbia University.
FAQ
What is the current stock price of Exponent (EXPO)?
What is the market cap of Exponent (EXPO)?
